Rosuvastatin INN 5mg & 10mg/tablet (f.c)

5mg x 28's pack: 350.00 MRP .

Indications: 

Corestin is indicated for patients with primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and exercise is inadequate. Corestin reduces elevated LDL-cholesterol, total cholesterol, triglycerides and ApoB, and increases HDL-cholesterol. Corestin is also indicated in patients with homozygous familial hypercholesterolaemia, either alone or as an adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis).

Method of administration:

Before initiating treatment with Corestin, the patient should be placed on a standard cholesterol-lowering diet that should continue during treatment. The dose of Corestin should be individualised according to the goal of therapy and patient response, using current consensus guidelines. The usual start dose is Corestin 10 mg once daily and the majority of patients are controlled at this dose. A dose adjustment to 20 mg can be made after 4 weeks, if necessary Corestin at a dose of 40 mg should only be used in patients with severe hypercholesterolaemia (including those with familial hypercholesterolaemia) who do not achieve their treatment goal on 20 mg. Corestin may be given at any time of day, with or without food.